DELX π DelphX Capital Markets - Overview
Exchange: V • Country: Canada • Currency: CAD • Type: Common Stock • ISIN: CA24721L1013
DELX: Securities, Derivatives, Data, Analytics, Research, Valuations
DelphX Capital Markets Inc. operates as a technology and financial services company in Canada and the United States. It develops and operates a global facility for transparent offering, purchase, sale, collection, and storage of various fixed income securities and derivatives, as well as to manage data, research, analytics, and valuations of instruments. DelphX Capital Markets Inc. is headquartered in Toronto, Canada. Web URL: https://www.delphx.com
Additional Sources for DELX Stock
DELX Stock Overview
Market Cap in USD | 16m |
Sector | Financial Services |
Industry | Capital Markets |
GiC Sub-Industry | Investment Banking & Brokerage |
IPO / Inception |
DELX Stock Ratings
Growth 5y | -20.1% |
Fundamental | -3.10% |
Dividend | - |
Rel. Strength Industry | -211 |
Analysts | - |
Fair Price Momentum | 0.10 CAD |
Fair Price DCF | - |
DELX Dividends
No Dividends PaidDELX Growth Ratios
Growth Correlation 3m | -46.6% |
Growth Correlation 12m | -17.1% |
Growth Correlation 5y | 2.3% |
CAGR 5y | -7.80% |
CAGR/Mean DD 5y | -0.13 |
Sharpe Ratio 12m | 0.19 |
Alpha | -53.06 |
Beta | 0.45 |
Volatility | 121.71% |
Current Volume | 0k |
Average Volume 20d | 13.5k |
What is the price of DELX stocks?
As of December 22, 2024, the stock is trading at CAD 0.11 with a total of 0 shares traded.
Over the past week, the price has changed by -15.38%, over one month by +4.76%, over three months by -15.38% and over the past year by -31.25%.
As of December 22, 2024, the stock is trading at CAD 0.11 with a total of 0 shares traded.
Over the past week, the price has changed by -15.38%, over one month by +4.76%, over three months by -15.38% and over the past year by -31.25%.
Is DelphX Capital Markets a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, DelphX Capital Markets is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -3.10 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of DELX as of December 2024 is 0.10. This means that DELX is currently overvalued and has a potential downside of -9.09%.
Neither. Based on ValueRay Fundamental Analyses, DelphX Capital Markets is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -3.10 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of DELX as of December 2024 is 0.10. This means that DELX is currently overvalued and has a potential downside of -9.09%.
Is DELX a buy, sell or hold?
DelphX Capital Markets has no consensus analysts rating.
DelphX Capital Markets has no consensus analysts rating.
What are the forecast for DELX stock price target?
According to ValueRays Forecast Model, DELX DelphX Capital Markets will be worth about 0.1 in December 2025. The stock is currently trading at 0.11. This means that the stock has a potential upside of +0%.
According to ValueRays Forecast Model, DELX DelphX Capital Markets will be worth about 0.1 in December 2025. The stock is currently trading at 0.11. This means that the stock has a potential upside of +0%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 0.1 | 0% |